Lipella Pharmaceuticals
(OTC) LIPO
Lipella Pharmaceuticals Financials at a Glance
Market Cap
$693,100
Revenue (TTM)
$173.67K
Net Income (TTM)
$5.33M
EPS (TTM)
$-2.41
P/E Ratio
-0.06
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$0.15
Volume
81
Open
$0.17
Price
$0.15
Volume
81
Open
$0.17
Previous Close
$0.15
Daily Range
$0.15 - $0.17
52-Week Range
$0.15 - $3.17
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$0.15
Volume
81
Open
$0.17
Previous Close
$0.15
Daily Range
$0.15 - $0.17
52-Week Range
$0.15 - $3.17
LIPO News
LIPO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lipella Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
Jonathan Kaufman, PhD, MBA
Website
www.lipella.comHeadquarters
Pittsburgh, PA 15208, US
LIPO Financials
Key Financial Metrics (TTM)
Gross Margin
-20%
Operating Margin
-31%
Net Income Margin
-31%
Return on Equity
-362%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
-16.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$693.10K
Shares Outstanding
4.62M
Volume
81
Short Interest
0.00%
Avg. Volume
4.92K
Financials (TTM)
Gross Profit
$3.08M
Operating Income
$5.08M
EBITDA
$5.01M
Operating Cash Flow
$3.95M
Capital Expenditure
$3.00
Free Cash Flow
$3.95M
Cash & ST Invst.
$2.18M
Total Debt
$47.60K
Lipella Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$720.97K
+31.1%
Gross Margin
0.00%
N/A
Market Cap
$693.10K
N/A
Market Cap/Employee
$138.62K
N/A
Employees
5
N/A
Net Income
$1.25M
+13.2%
EBITDA
$1.27M
+12.7%
Quarterly Fundamentals
Net Cash
$1.59M
+24.1%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$219.82K
N/A
Short Term Debt
$44.27K
-37.5%
Return on Assets
-2.27%
N/A
Return on Invested Capital
-3.17%
N/A
Free Cash Flow
$2.36B
-360909.2%
Operating Cash Flow
$2.36B
-360909.2%